Blog
DGAP-News: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds
DGAP-News: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds
Edison Investment Research Limited: Edison issues initiation on Stern Groep (STRN)
Edison Investment Research Limited: Edison issues initiation on Stern Groep (STRN)
Form 8.3 - The Vanguard Group, Inc.: William Hill plc
Form 8.3 - The Vanguard Group, Inc.: William Hill plc
Form 8.3 - The Vanguard Group, Inc.: G4S plc
Form 8.3 - The Vanguard Group, Inc.: G4S plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: TalkTalk Telecom Group plc
Form 8.3 - The Vanguard Group, Inc.: TalkTalk Telecom Group plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
DGAP-Adhoc: QIAGEN N.V.: QIAGEN reports strong preliminary results for third quarter of 2020
DGAP-Adhoc: QIAGEN N.V.: QIAGEN reports strong preliminary results for third quarter of 2020
DGAP-News: Linde Announces Third Quarter 2020 Earnings and Conference Call Schedule
DGAP-News: Linde Announces Third Quarter 2020 Earnings and Conference Call Schedule
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
DGAP-News: Mutares SE & Co. KGaA: Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.
DGAP-News: Mutares SE & Co. KGaA: Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.
Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
DGAP-News: Aspera License Management solution receives SAP netweaver(R) certification
DGAP-News: Aspera License Management solution receives SAP netweaver(R) certification
DGAP-News: Wacker Chemie AG: WACKER Expands Capacity for Polymer Products at Nanjing
DGAP-News: Wacker Chemie AG: WACKER Expands Capacity for Polymer Products at Nanjing
DGAP-News: Tele Columbus AG: Bauverein der Elbgemeinden eG selects Tele Columbus to provide more fibre
DGAP-News: Tele Columbus AG: Bauverein der Elbgemeinden eG selects Tele Columbus to provide more fibre
PJSC Magnitogorsk Iron and Steel Works: MMK Group Trading Update for Q3 and 9M 2020
PJSC Magnitogorsk Iron and Steel Works: MMK Group Trading Update for Q3 and 9M 2020
Pharnext to Host Research and Development Event Today
Pharnext to Host Research and Development Event Today
Transactions in own shares
Transactions in own shares
DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital
DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital
DGAP-Adhoc: Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
DGAP-Adhoc: Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
DGAP-News: HYPOPORT SE: further market share gains in the first nine months of 2020
DGAP-News: HYPOPORT SE: further market share gains in the first nine months of 2020
EQS-News: NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
EQS-News: NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
DGAP-News: Gerresheimer AG: Gerresheimer on track for strong second half-year
DGAP-News: Gerresheimer AG: Gerresheimer on track for strong second half-year
DGAP-News: Formycon Receives Funding for COVID-19 Drug Research from the Bavarian Research Foundation
DGAP-News: Formycon Receives Funding for COVID-19 Drug Research from the Bavarian Research Foundation


